Delta Global Management LP Invests $2.57 Million in Intuitive Surgical, Inc. $ISRG

Delta Global Management LP bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,743 shares of the medical equipment provider’s stock, valued at approximately $2,568,000.

A number of other large investors have also added to or reduced their stakes in ISRG. Kilter Group LLC bought a new position in Intuitive Surgical during the second quarter worth $27,000. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at $27,000. Caitlin John LLC bought a new position in shares of Intuitive Surgical in the third quarter valued at about $30,000. Guerra Advisors Inc acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $37,000. Finally, Riggs Asset Managment Co. Inc. lifted its stake in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 32 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 into cardiac surgery, opening a much larger long-term TAM (management cites a jump from ~17k to ~160k addressable procedures in cleared markets) — a multi-year growth driver for procedure volume and consumables. Read More.
• Positive Sentiment: Completed acquisition of Southern Europe distributor businesses (Italy, Spain, Portugal) shifts da Vinci and Ion sales to direct operations — should improve control of regional sales/service and capture margin/recurring revenue over time. Read More.
• Positive Sentiment: Sell-side momentum: Citigroup upgraded ISRG to Buy and several analysts maintain bullish price targets, supporting upside thesis and sentiment. Read More.
• Positive Sentiment: Recent Q4 results beat consensus (strong revenue and EPS growth), reinforcing recurring-consumables revenue and the upgrade cycle for da Vinci systems. Read More.
• Neutral Sentiment: Analyst consensus shows meaningful upside (Zacks highlights ~29.7% average target upside), but that depends on execution and multiple expansion remaining intact. Read More.
• Neutral Sentiment: Long-form bullish pieces reiterate a multi-year growth story from da Vinci 5, Ion and software/services but don’t change near-term valuation concerns. Read More.
• Negative Sentiment: Cybersecurity incident (phishing-linked breach affecting internal systems) is the immediate catalyst for the share decline — investors will watch for customer impact, data exposure, and remediation costs. Read More.
• Negative Sentiment: Insider selling (recent EVP share sales) and management guidance calling for a deceleration in worldwide da Vinci procedure growth in 2026 could pressure near-term sentiment and valuation. Read More. • Read More.

Analyst Ratings Changes

A number of research analysts recently commented on ISRG shares. Piper Sandler reiterated an “overweight” rating and issued a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Royal Bank Of Canada upped their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Finally, Argus lowered their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $615.86.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $472.16 on Monday. The firm has a market cap of $167.68 billion, a P/E ratio of 59.84, a price-to-earnings-growth ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The business’s fifty day moving average is $513.26 and its 200-day moving average is $512.96.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter last year, the business earned $2.21 earnings per share. Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.